Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain

[1]  S. Qin,et al.  Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer. , 2015, Oncology reports.

[2]  Junnian Zheng,et al.  Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer , 2015, Oncotarget.

[3]  D. Parmar,et al.  Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? , 2014, Tumor Biology.

[4]  Hong Wang,et al.  Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. , 2014, Cancer letters.

[5]  Jun Liang,et al.  Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy , 2013, World Journal of Surgical Oncology.

[6]  R. Kalluri,et al.  Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.

[7]  Deyong Yang,et al.  Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients , 2013, Oncology letters.

[8]  K. Baldwin,et al.  Gallbladder cancer: past, present and an uncertain future. , 2012, Surgical oncology.

[9]  Mridula Shukla,et al.  Survivin expression and targeting in breast cancer. , 2012, Surgical oncology.

[10]  M. Pandey,et al.  Molecular alterations in gallbladder cancer , 2012 .

[11]  M. Pandey,et al.  Survivin Expression and Correlation with Clinico-pathological Parameters in Breast Cancer , 2012 .

[12]  Tae Yong Kim,et al.  Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder , 2011, Journal of Korean medical science.

[13]  Myung Ah Lee,et al.  Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer , 2010, BMC Cancer.

[14]  H. Kashkar.  X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise , 2010, Clinical Cancer Research.

[15]  L. Languino,et al.  IAP regulation of metastasis. , 2010, Cancer cell.

[16]  B. Fraile,et al.  Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate , 2010, BMC Cancer.

[17]  T. Wang,et al.  p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[18]  T. Pawlik,et al.  Evolving Treatment Strategies for Gallbladder Cancer , 2009, Annals of Surgical Oncology.

[19]  Salma Khan,et al.  Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential , 2009, British Journal of Cancer.

[20]  G. Torzilli,et al.  Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma , 2009, BMC Cancer.

[21]  N. Coburn,et al.  Surgery for gallbladder cancer: a population-based analysis. , 2008, Journal of the American College of Surgeons.

[22]  S. Srinivasula,et al.  IAPs: what's in a name? , 2008, Molecular cell.

[23]  M. Ahmed,et al.  Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. , 2007, Singapore medical journal.

[24]  E. Ross,et al.  Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer , 2007, Clinical Cancer Research.

[25]  M. Monden,et al.  Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer , 2007, British Journal of Cancer.

[26]  S. Yie,et al.  Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA , 2006, Clinical & Experimental Metastasis.

[27]  S. Kahlert,et al.  Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  D. Wei.  Expression of laminin and survivin in primary gallbladder carcinoma , 2006 .

[29]  John Calvin Reed,et al.  Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers , 2005, Clinical Cancer Research.

[30]  L. O’Driscoll,et al.  Prognostic importance of survivin in breast cancer , 2003, British Journal of Cancer.

[31]  D. Altieri,et al.  Survivin in apoptosis control and cell cycle regulation in cancer. , 2003, Progress in cell cycle research.

[32]  A. Cheung,et al.  Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. , 2001, European journal of cancer.

[33]  J C Reed,et al.  Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  Yangyili,et al.  The IAP family：endogenous caspase inhibitors with multiple biological activities , 2000 .

[35]  K. Chijiiwa,et al.  Carcinoma of the gallbladder: an appraisal of surgical resection. , 1994, Surgery.